Paul Tudor Jones's EHC Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 30,730 shares of Encompass Health Corporation (EHC) worth $2.97 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in EHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 128,191 shares. Largest reduction occurred in Q1 2026, reducing 294,056 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Encompass Health Corporation (EHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Encompass Health Corporation (EHC) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -294,056 | Reduce 90.54% | 30,730 | $96.73 |
| Q4 2025 | +114,074 | Add 54.14% | 324,786 | $106.14 |
| Q3 2025 | +128,191 | Add 155.34% | 210,712 | $127.02 |
| Q2 2025 | +75,882 | Add 1142.97% | 82,521 | $122.63 |
| Q1 2025 | +2,689 | Add 68.08% | 6,639 | $101.28 |
| Q4 2024 | +1,482 | Add 60.05% | 3,950 | $92.35 |
| Q3 2024 | -10,177 | Reduce 80.48% | 2,468 | $96.64 |
| Q2 2024 | +9,876 | Add 356.66% | 12,645 | $85.79 |
| Q1 2024 | -1,254 | Reduce 31.17% | 2,769 | $82.58 |
| Q4 2023 | -32,711 | Reduce 89.05% | 4,023 | $66.72 |
| Q3 2023 | +36,734 | New Buy | 36,734 | $67.16 |
| Q2 2023 | -5,683 | Sold Out | 0 | $0.00 |
| Q1 2023 | +5,683 | New Buy | 5,683 | $0.05 |
| Q1 2022 | -8,604 | Sold Out | 0 | $0.00 |
| Q4 2021 | -19,051 | Reduce 68.89% | 8,604 | $65.20 |
| Q3 2021 | +23,525 | Add 569.61% | 27,655 | $75.03 |
| Q2 2021 | -18,752 | Reduce 81.95% | 4,130 | $77.97 |
| Q1 2021 | +22,882 | New Buy | 22,882 | $81.90 |
| Q2 2020 | -10,855 | Sold Out | 0 | $0.00 |
| Q1 2020 | +10,855 | New Buy | 10,855 | $64.03 |
| Q3 2019 | -45,279 | Sold Out | 0 | $0.00 |
| Q2 2019 | -5,818 | Reduce 11.39% | 45,279 | $63.36 |
| Q1 2019 | +36,113 | Add 241.01% | 51,097 | $58.40 |
| Q4 2018 | +14,984 | New Buy | 14,984 | $61.73 |
| Q3 2018 | -40,182 | Sold Out | 0 | $0.00 |
| Q2 2018 | +30,699 | Add 323.73% | 40,182 | $67.72 |
| Q1 2018 | +9,483 | New Buy | 9,483 | $57.15 |
Paul Tudor Jones's Encompass Health Corporation Investment FAQs
Paul Tudor Jones first purchased Encompass Health Corporation (EHC) in Q1 2018, acquiring 9,483 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Encompass Health Corporation (EHC) for 27 quarters since Q1 2018.
Paul Tudor Jones's largest addition to Encompass Health Corporation (EHC) was in Q3 2025, adding 210,712 shares worth $26.76 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 30,730 shares of Encompass Health Corporation (EHC), valued at approximately $2.97 M.
As of the Q1 2026 filing, Encompass Health Corporation (EHC) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Encompass Health Corporation (EHC) was 324,786 shares, as reported at the end of Q4 2025.